http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2346678-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eec8f3c86896e565a6418bbc5644380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc3fd64500d64c1eaeda378bde6e1aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc7ff6c5930fc32f169953a270a52e3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d32cb25c36a7cc6a1640e3a73c0b20ba
publicationDate 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2346678-C1
titleOfInvention Method of treatment of central vein thrombosis of retina
abstract FIELD: medicine; ophthalmology. n SUBSTANCE: invention can be used for surgical treatment of central vein thrombosis of retina (RCV). Induction of chorioretinal anastomosis (CRA) is performed by laser radiation of RCV of the third order with wave length 532 nm, four coagulates in number, radiation power density 500 mW/cm 2 , pulse duration 1 second, spot diameter 50 mcm. Vitrectomy is preliminary carried out with removed posterior hyaloid membrane of vitreous body. It is followed with perioperative endolaser CRA induction and, additionally paravasal endolaser retina coagulation at wave length 532 nm, 500-600 coagulates in number, radiation power density 120-200 mW/cm 2 , pulse duration 0.1-0.2 seconds, spot diameter 50-200 mcm. n EFFECT: higher efficiency of surgical treatment of RCV thrombosis based on combined vitrectomy, removal of posterior hyaloid membrane of vitreous body (PHMVB), perioperative endolaser CRA induction and paravasal panretinal endolaser retina coagulation. n 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2603318-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2553388-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2749122-C1
priorityDate 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573

Total number of triples: 20.